Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
258.99 USD344.70 USD430.46 USD
-43.94%
344.70 USDCurrent price is 43.9% below the base model value.
B
HealthcareDrug Manufacturers - GeneralUnited States
BIIB.US · Biogen Inc.
NMS · US · USD
Latest price193.25 USD
30D+1.32%
Vs. base value+34.2%
Research summary
BIIB.US latest organized financial period shows revenue grew +2.22% YoY and net income declined -20.79% YoY. Current price is about 193 USD, while the model base case is about 144 USD; the current price sits +34.2% versus the base case. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue10B USD
Net income1B USD
Free cash flow2B USD
Operating cash flow2B USD
Price trend
Price date: 2026/04/28 · Updated: 2026/04/29 07:24
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price193.25 USD
Base value143.95 USD
Vs. base+34.2%
Price date2026/04/28
143.95 USD143.95 USD146.61 USD
+34.25%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
116.50 USD108.89 USD136.53 USD
+77.47%
108.89 USDCurrent price is 77.5% above the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth0.7%
Current price implies roughly 0.7% annualized FCF growth.
0.7%Current price implies roughly 0.7% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
131.23 USD131.23 USD131.23 USD
+47.26%
131.23 USDCurrent price is 47.3% above the base model value.
Updated: 2026/04/29 07:24
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 9
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | 10B USD | 1B USD | 2B USD | 8.79 |
| 2024/12/30 | Annual | 10B USD | 2B USD | 3B USD | 11.18 |
| 2023/12/30 | Annual | 10B USD | 1B USD | 1B USD | 7.97 |
| 2022/12/30 | Annual | 10B USD | 3B USD | 1B USD | 20.87 |
| 2021/12/30 | Annual | - | - | - | - |
Ad placement